FDA label
What is Vemlidy used for?
Vemlidy contains tenofovir alafenamide. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “VEMLIDY is indicated for the treatment of chronic hepatitis B virus (HBV) infection in adults and pediatric patients 6 years of age and older and weighing at least 25 kg with compensated liver disease.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Vemlidy?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Vemlidy, tablet
Indications and Usage, quoted from the label by Gilead Sciences, Inc. (NDA208464). Cross-references to other label sections are left out.
VEMLIDY is indicated for the treatment of chronic hepatitis B virus (HBV) infection in adults and pediatric patients 6 years of age and older and weighing at least 25 kg with compensated liver disease.
Source: DailyMed label, set id 72e6b33c-0351-4070-9172-eeaa186c01d2, version 17, effective July 14, 2025. NDC 61958-2301, one of 1 listing for this product.
Questions
What is Vemlidy used for?
The FDA label says: “VEMLIDY is indicated for the treatment of chronic hepatitis B virus (HBV) infection in adults and pediatric patients 6 years of age and older and weighing at least 25 kg with compensated liver disease.”
What drug class is Vemlidy?
FDA lists tenofovir alafenamide in the Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor and Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.
More on Vemlidy
- Is Vemlidy a controlled substance?Federal schedule
- Generic for VemlidyFDA Orange Book
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitors listFDA drug class
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitors listFDA drug class
- Vemlidy Medicare Part D coverageBy plan and state
- NDC 61958-2301Vemlidy NDC record